Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt
Omar, H., El Akel, W., Elbaz, T., El Kassas, M., Elsaeed, K., El Shazly, H., Said, M., Yousif, M., Gomaa, A. A., Nasr, A., AbdAllah, M., Korany, M., Ismail, S. A., Shaker, M. K., Doss, W., Esmat, G.,Language:
english
Journal:
Alimentary Pharmacology & Therapeutics
DOI:
10.1111/apt.14428
Date:
November, 2017
File:
PDF, 603 KB
english, 2017